New EHRA Practical Guide on non-vitamin K antagonist oral anticoagulants launched
Stress of open-heart surgery significantly reduces vitamin D levels, but supplementation helps
Alirocumab reduces cardiovascular events after acute coronary syndrome
Statins may bring benefits at time of treatment for percutaneous coronary intervention
Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad population of patients slated to undergo percutaneous coronary intervention (PCI), but statins did significantly reduce the rates of such events among the subset of trial participants who actually underwent PCI.